A non-profit organization dedicated to harnessing the immune system's power to control and potentially cure all types of cancer through research, awareness, and immunotherapy development.

Cancer Research Institute

American Cancer Society provides information, resources, and support for cancer patients and their families. It conducts research, facilitates patient programs, and promotes cancer prevention and awareness.

American Cancer Society

Sbarro Health Research Organization is a nonprofit charity committed to funding excellence in basic genetic research to cure and diagnose cancer, cardiovascular diseases, diabetes, and other chronic illnesses, and to foster the training of young doctors in a spirit of professionalism and humanism. Self-described.

Sbarro Health Research Organization

Founded in 1953, the New York City-based Cancer Research Institute is a nonprofit organization dedicated to extending the lives of cancer patients and reducing cancer-related deaths by fueling the development of smarter, more effective treatments that mobilize our body’s natural immune defenses against all types of cancer.

To accomplish this goal, the Cancer Research Institute supports the most critical research, invests in the development of promising new treatments, and unites the efforts of the field’s leaders worldwide. Through this work, Cancer Research Institute is transforming cancer therapy, enabling patients to live longer, healthier lives free from the fear of cancer. 

For more information visit www.cancerresearch.org.

Cancer Research Institute (CRI)

Did you know? The Cancer Research Institute is ranked among the top 5% of all U.S. rated charities. Give with confidence, and make an impact by donating today to fund lifesaving cancer immunotherapy research: https://bit.ly/44of8ML #CancerResearch #Immunotherapy #CharityRatings #GiveWithConfidence

"CICON is the only meeting I can think of that brings together so many experts in the field to network and collaborate," says Dr. Elizabeth M. Jaffee, Meeting Co-Chair, and Deputy Director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Medicine. Register to attend #CICON24 by July 15 to receive early-bird pricing! Sign up today, and save: https://bit.ly/3wkc5sQ #CancerResearch #CICON #CancerResearcher #Immunotherapy

Today is Glioblastoma Awareness Day. Understand why GBM is such a deadly type of cancer, hear a patient's story of survival, and discover how CRI-funded researchers are improving patient outcomes, in our new blog post. "Every patient with glioblastoma [whom] I have ever had the privilege of treating is full of resolve, hope, fortitude, and courage," shares CRI Lloyd J. Old STAR Dr. Gavin Dunn of Massachusetts General Hospital. "We owe it to our patients to study their brain cancers and improve their lives." Read more: https://bit.ly/3WaiNeb #GlioblastomaAwarenessDay #GBM #Glioblastoma #CancerResearch #Immunotherapy

“Without a shadow of a doubt, immunotherapy saved my life,” expresses Jeff, a melanoma survivor. Discover the transformative impact of immunotherapy, and gain insight into a patient's perspective, through Jeff's first-hand account of his immunotherapy journey: https://bit.ly/4cQ7Gh9 #CancerResearch #Immunotherapy #CRISummit #Melanoma

Published in Springer Nature Group's Nature Medicine, findings from a small clinical trial suggest that a new cellular immunotherapy approach could be effective in treating metastatic solid tumors. Researchers from The National Institutes of Health, including 2020 American Association for Cancer Research- CRI Lloyd J. Old Award recipient Dr. Steven Rosenberg, genetically engineered lymphocytes from each patient to produce receptors that recognize and attack their cancer cells. The personalized immunotherapy shrank tumors in some patients, and was able to halt tumor regrowth for up to seven months. “It's just the very beginning of converting normal lymphocytes into cells capable of treating the common solid cancers,” says Dr. Rosenberg. “What this study shows is that it's possible. Once you know it’s possible, you work to improve it.” Read more: https://bit.ly/3xUJoUs #ColorectalCancer #Immunotherapy #CancerResearch

Register today to discover Pancreatic Cancer Demystified: Expert Insights and Breakthroughs with Robert H. Vonderheide, MD, DPhil!
 
Pancreatic cancer, often termed “the silent killer,” is a relentless and merciless adversary. Ranking as the world’s most lethal form of cancer, it is currently the fourth leading cause of cancer-related deaths in United States.  

Why is pancreatic cancer so difficult to diagnose? What treatment options are available against such a deadly foe? Join us on June 26 for an exclusive, live webinar featuring renowned cancer immunologist, CRI Scientific Advisory Council member, and Clinical Accelerator Investigator, Robert H. Vonderheide, MD, DPhil, from the Abramson Cancer Center of the University of Pennsylvania.

Dr. Vonderheide will delve into these pressing questions and provide a deeper dive into the latest advances in immunotherapy for pancreatic cancer patients. This is a unique opportunity to gain invaluable insights from one of the leading experts in the field. #CancerResearch #PancreaticCancer

Metric
Company Name	Cancer Research Institute	American Cancer Society	Sbarro Health Research Organization
Symbol
MSH ID	ORG:CANCERRESEARCH	ORG:CANCER	ORG:SHRO
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Cancer Research and Treatment	Non-profit Organizations	Research & Development
Country	US	US	US
Stage
Employee Count	120
Website	cancerresearch.org	cancer.org	shro.org
LinkedIn	the-cancer-research-institute
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	49.02K
Web Traffic Growth	-0.01
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

CANC

ORG:CANCERRESEARCH

Cancer Research Institute

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue